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Abstract  
An 81-year-old male presented with an ulcerated lesion on the frontal area. The lesion had started three years 
before with a small ulceration and was initially treated with a cream of betamethasone and fusidic acid twice daily 
for several months. The clinical impression was ulcerated basal cell carcinoma (BCC).The histopathological 
findings after surgical excision were consistent with metatypical or basosquamous carcinoma.  The importance of 
metatypical and basosquamous carcinomas is their potential for a more aggressive behaviour than conventional 
BCC, both regarding local recurrences and metastatic disease. Clinicians should be aware of the more aggressive 
behaviour of metatypical BCC since it may influence the protocols of follow-up of these patients to timely detect 
local recurrences and/or metastatic disease. 
 
 
 
 
 
 
 
 
 
An 81-year-old male presented with an 
ulcerated lesion on the frontal area. The lesion had 
started three years before with a small ulceration and 
was initially treated with a cream of betamethasone 
and fusidic acid twice daily for several months. Later, 
silver sulphadiazine cream was also applied. No 
investigations had been performed before the patient 
presented to the Dermatology Department, namely a 
biopsy. Examination disclosed an ulcerated lesion 
with a large depressed central area covered with a 
haemorrhagic crust and surrounded by an elevated 
border with a mildly erythematous colour and 
telangiectasia (Figure 1a).  
The clinical impression was ulcerated basal 
cell carcinoma (BCC). Previous medical history was 
only remarkable for benign prostate hyperplasia 
without any other significant comorbidities. Excision of 
the lesion was performed under local anaesthesia 
followed by direct closure with tissue expansion 
(Figures 1b, 1c, and 1d). 
 
Figure 1a: Ulcerated lesion on the frontal area with erythematous 
telangiectatic border  
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Histopathological examination of the excision 
specimen revealed an ulcerated epithelial neoplasm 
composed of nodules and strands containing medium-
sized basophilic cells with scant cytoplasm and round 
to oval nuclei with retraction artefact and only a focal 
hint of peripheral palisading. 
 
Figure 1b: Excision of the lesion 
 
The centre of the epithelial structures 
frequently contained larger cells with more abundant 
eosinophilic cytoplasm, more pleomorphic nuclei and 
central keratinization (Figures 1e, 1f, 1g and 1h). 
 
Figure 1c: Resulting surgical defect 
Figure 1d: Immediate post-operative result after direct closure  
 
These findings were consistent with 
metatypical or basosquamous carcinoma. The patient 
had no palpable lymphadenopathy, and an ultrasound 
of the head/neck, axillary and inguinal regions did not 
reveal any enlarged lymph nodes. A complete blood 
count and blood chemistry panel were unremarkable. 
 
Figure 1e: Epithelial neoplasm in the dermis composed of nodules 
and strands of basaloid cells (left side), and cells with more 
abundant eosinophilic cytoplasm and keratinization (right side).  
 
The patient has been under follow-up for four 
months, and no sign of recurrence was detected to 
date. 
The terms metatypical BCC and 
basosquamous carcinoma are often used 
interchangeably to describe tumours with features of 
BCC with foci of neoplastic squamous differentiation, 
i.e., tumours with intermediate or mixed features of 
BCC and squamous cell carcinoma (SCC). This is not 
to be confused with BCC with keratinization or 
keratotic BCC, which is a rather more common 
occurrence in comparison to metatypical BCC. 
 Cardoso et al. Ulcerated Metatypical Basal Cell Carcinoma of the Forehead  
_____________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2017 Oct 15; 5(6):807-809.                                                                                                                                                         809 
 
 
Figure 1f: Ulceration with thick crust overlying the epithelial 
neoplasm 
 
However, some authors reserve the term 
metatypical BCC to tumours with typical areas of BCC 
merging with areas containing cells with intermediate 
features between BCC and SCC, namely a more 
abundant cytoplasm and higher grade atypia but, 
notably, no significant keratinisation. For these 
authors, the term basosquamous carcinoma should 
be reserved for BCC with differentiation towards areas 
indistinguishable from SCC, including keratinisation, 
with intermediate (metatypical) areas between the two 
[1, 2]. 
 
Figure 1g: Basaloid nodules with focal peripheral palisading and 
retraction artefact  
Architecturally, these tumours are often 
characterized by an infiltrative growth pattern. 
 
Figure 1h: Nodule composed of epithelial cells with abundant 
eosinophilic cytoplasm (upper half) and smaller nodules of basaloid 
cells (lower half)  
 
The importance of metatypical and 
basosquamous carcinomas is their potential for a 
more aggressive behaviour than conventional BCC, 
both regarding local recurrences and metastatic 
disease [3]. A significant proportion of cases of 
metastatic BCC are found to display features of 
basosquamous carcinoma [4, 5]. Metatypical BCC is 
more common among giant non-melanoma skin 
cancers [5]. 
Clinicians should be aware of the more 
aggressive behaviour of metatypical BCC since it may 
influence the protocols of follow-up of these patients 
to timely detect local recurrences and/or metastatic 
disease.  
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